An FDA advisory panel gives a mixed view in its unprecedented 3rd review of Boston Scientific's Watchman anti-stroke device.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1v45IlU
An FDA advisory panel gives a mixed view in its unprecedented 3rd review of Boston Scientific's Watchman anti-stroke device.
Cap comentari:
Publica un comentari a l'entrada